AlphaCore Capital’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$854K Buy
2,773
+338
+14% +$105K 0.01% 568
2026
Q2
$682K Sell
2,435
-3,532
-59% -$928K 0.01% 568
2026
Q1
$1.59M Buy
5,967
+686
+13% +$186K 0.04% 295
2025
Q4
$1.32M Buy
5,281
+1,915
+57% +$509K 0.03% 346
2025
Q3
$966K Buy
3,366
+419
+14% +$112K 0.03% 307
2025
Q2
$774K Buy
+2,947
New +$718K 0.03% 297

Other funds holding LH

AlphaCore Capital's LH Position: Q3 2026 in Review

AlphaCore Capital increased its Labcorp (LH) stake by 14% in Q3 2026, buying an estimated $105K and bringing the position to 2,773 shares worth $854K. The position accounts for 0.01% of the portfolio, ranked #568.

AlphaCore Capital first reported a position in LH in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.59M in Q1 2026. 471 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • AlphaCore Capital held 2,773 shares of Labcorp worth $854K as of Q3 2026.
  • AlphaCore Capital bought 338 Labcorp shares in Q3 2026, an estimated $105K.
  • Labcorp made up 0.01% of AlphaCore Capital's portfolio in Q3 2026, its #568 holding.
  • AlphaCore Capital first reported a position in Labcorp in Q2 2025 and has held it in 6 quarters since.
  • AlphaCore Capital's Labcorp position peaked at $1.59M in Q1 2026.
  • 471 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on AlphaCore Capital's 13F filing for Q3 2026, filed 4 Nov 2026.